ANROVSNRSN• 3 Months (Normalized)
ANRO vs NRSN (Alto Neuroscience Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+575.14%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-575.14 pts
NRSN outperforming by 575.14 percentage points
ANRONRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ANRO Price | ANRO Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +575.14% | - | |
| Sep 28, 2026 | $- | $5.10 | +620.34% | - | |
| Sep 25, 2026 | $- | $6.95 | +881.64% | - | |
| Sep 24, 2026 | $- | $7.40 | +945.20% | - | |
| Sep 23, 2026 | $27.50 | +10.98% | $7.40 | +945.20% | -934.22% |
| Sep 22, 2026 | $30.78 | +24.21% | $7.18 | +914.12% | -889.91% |
| Sep 21, 2026 | $30.63 | +23.61% | $6.62 | +835.03% | -811.42% |
| Sep 18, 2026 | $30.27 | +22.15% | $6.35 | +796.89% | -774.74% |
| Sep 17, 2026 | $30.98 | +25.02% | $6.72 | +849.15% | -824.13% |
| Sep 16, 2026 | $30.00 | +21.07% | $6.49 | +816.67% | -795.60% |
| Sep 15, 2026 | $30.25 | +22.07% | $7.03 | +892.94% | -870.87% |
| Sep 14, 2026 | $31.68 | +27.85% | $6.90 | +874.58% | -846.73% |
| Sep 11, 2026 | $32.00 | +29.14% | $0.35 | -50.99% | +80.13% |
| Sep 10, 2026 | $31.68 | +27.85% | $0.33 | -53.11% | +80.96% |
| Sep 09, 2026 | $34.07 | +37.49% | $0.40 | -43.36% | +80.85% |
Page 1 of 5